CLINICAL ROLE -
Which Rx-to-OTC Switches Could Be on the Horizon?
Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.
Watch
High Cost Drug Launches in Specialty Pharmacy
Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.
Treating Chronic Conditions in Specialty Pharmacy
Eric Peacock, CEO of MyHealthTeams, discusses effective treatment of patients with chronic conditions.
Staying Focused on Common Goals in Specialty Pharmacy
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses how the needs of specialty pharmacy, payers, and manufacturers can be aligned.
Factors That Could Impact Specialty Pharmacy Patients
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.
Enhanced Collaboration Among Specialty Stakeholders
Rinku A. Patel, PharmD, RPh, discusses how to improve communication among patients, physicians, pharmacists, and payers.
How Specialty Pharmacies Can Gain Access to Limited Distribution Drugs
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can best position themselves to access limited distribution drugs.
ACO Growth and Specialty Pharmacies
Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies will be impacted by the growth of accountable care organizations.
Access to Specialty Drugs Remains a Challenge
Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses how specialty pharmacies can help patients gain access to costly specialty drug regimens.
Streamlining Relationships Among Specialty Pharmacy Stakeholders
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses how communication can be improved among specialty pharmacies, manufacturers, and pharmacy benefit managers.
Biosimilars in Specialty Pharmacy
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Optimal Management Programs Vital to Specialty Patient Success
Rebekah L. Hanson, PharmD, BCPS, BCACP, discusses the elements of an effective patient management program in specialty pharmacy.
Overcoming High Out-of-Pocket Costs in Specialty Pharmacy
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how pharmacies can help patients manage high drug costs.
Managing Effective Specialty Drug Distribution
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.
Alignment Between Specialty Pharmacy and ACOs
Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how specialty pharmacies can help achieve the goals of accountable care organizations.
Helping Patients Manage High Medication Co-pays
Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.
Limitations in Prior Authorizations for Specialty Drugs
Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the impact of prior authorizations on specialty pharmacy.
How Will Drug Costs Impact the Specialty Pharmacy Patient Experience?
Grant E. Knowles, PharmD, discusses how the projected growth in specialty drug spending may change the patient experience in the years ahead.
How to Improve Adherence to Specialty Drugs
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how to optimize a drug adherence program in specialty pharmacy.
Are There Interactions Between Certain Medications, Nutraceuticals That Pharmacists Should Counsel About?
Pharmacists need to remain aware of certain interactions that can occur with medications and nutraceuticals.
What Role Do Pharmacists Play in Educating About Nutraceuticals?
Patients can use guidance about what vitamin products to select for their use.
Getting Patients to Take an Active Role in Their Own Care
Eric Peacock, co-founder and CEO of MyHealthTeams, discusses the importance of specialty pharmacies collaborating with patients in their care.
Maintaining Adherence as Out of Pocket Costs Rise
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.
The Long-Term Impact of Biosimilars
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
How Value-based Care Could Affect Specialty Pharmacy
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.
Effective Medication Therapy Management in Specialty Pharmacy
Jonathan Van Lare, PharmD, director of Clincal Services at Pharmacy Advantage, discusses the elements of a successful specialty pharmacy therapy management program.
Scrutiny Continues to Grow Around the Cost of Specialty Drugs
Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.
Greater Competition and Specialty Drug Costs
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.
How Can Pharmacists Maintain Adherence?
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses methods pharmacists can employ to maintain adherence.
Quality Metrics That Define Specialty Pharmacy
Daniel P. Kus, BS Pharm, RPh, vice president, Pharmacy Advantage, discusses key quality measures that define successful specialty pharmacies.
